Comirnaty and Pfizer-BioNTech COVID-19 Vaccine | FDA

June 17, 2022: FDA authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for children down to 6 months of age. View press release and press conference.

On August 23, 2021, FDA announced the first approval of a COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for the prevention of COVID-19 in individuals 16 years of age and older.

Pfizer-BioNTech COVID-19 Vaccine is authorized for emergency use as a:

On February 11, 2022, in consultation with FDA, CDC updated the emergency use instructions to provide information about the primary, additional, and booster doses of the Pfizer COVID-19 vaccines in certain individuals.

06/29/2022

View original post here:

Comirnaty and Pfizer-BioNTech COVID-19 Vaccine | FDA

Related Posts
Tags: